Nandi Li

446 total citations
14 papers, 371 citations indexed

About

Nandi Li is a scholar working on Cancer Research, Molecular Biology and Epidemiology. According to data from OpenAlex, Nandi Li has authored 14 papers receiving a total of 371 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Cancer Research, 10 papers in Molecular Biology and 3 papers in Epidemiology. Recurrent topics in Nandi Li's work include Cancer-related molecular mechanisms research (11 papers), RNA modifications and cancer (8 papers) and Circular RNAs in diseases (4 papers). Nandi Li is often cited by papers focused on Cancer-related molecular mechanisms research (11 papers), RNA modifications and cancer (8 papers) and Circular RNAs in diseases (4 papers). Nandi Li collaborates with scholars based in China and United States. Nandi Li's co-authors include Jiancheng Tu, Jing Wei, Chunzi Liang, Ping Luo, Xuefang Liu, Man Zhu, Yingchao Wang, Mingxia Yu, Man Zhu and Qian Tan and has published in prestigious journals such as Oncotarget, International Journal of Oncology and Cellular Physiology and Biochemistry.

In The Last Decade

Nandi Li

14 papers receiving 370 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nandi Li China 10 341 317 42 17 16 14 371
Kelin She China 9 299 0.9× 302 1.0× 21 0.5× 26 1.5× 27 1.7× 11 361
Qiming Shen China 7 165 0.5× 181 0.6× 25 0.6× 19 1.1× 11 0.7× 13 204
Miaojun Zhu China 4 403 1.2× 376 1.2× 22 0.5× 17 1.0× 42 2.6× 6 436
Changyi Fang China 5 309 0.9× 305 1.0× 48 1.1× 23 1.4× 8 0.5× 5 342
Shuzhi Zang China 7 290 0.9× 297 0.9× 24 0.6× 16 0.9× 27 1.7× 8 333
Chunni Fan China 6 291 0.9× 282 0.9× 18 0.4× 30 1.8× 37 2.3× 8 343
Sen Meng China 8 215 0.6× 271 0.9× 24 0.6× 41 2.4× 24 1.5× 9 315
Serena Di Cecilia United States 4 331 1.0× 441 1.4× 19 0.5× 33 1.9× 15 0.9× 4 495

Countries citing papers authored by Nandi Li

Since Specialization
Citations

This map shows the geographic impact of Nandi Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nandi Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nandi Li more than expected).

Fields of papers citing papers by Nandi Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nandi Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nandi Li. The network helps show where Nandi Li may publish in the future.

Co-authorship network of co-authors of Nandi Li

This figure shows the co-authorship network connecting the top 25 collaborators of Nandi Li. A scholar is included among the top collaborators of Nandi Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nandi Li. Nandi Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Ming, Xinliang, Shili Qiu, Xuefang Liu, et al.. (2019). Prognostic Role of Tenascin-C for Cancer Outcome: A Meta-Analysis. Technology in Cancer Research & Treatment. 18. 1077088754–1077088754. 8 indexed citations
2.
Luo, Ping, Xiaobo Feng, Jing Wei, et al.. (2018). Clinical and Diagnostic Significance of Homer1 in hepatitis B virus-induced Hepatocellular Carcinoma. Journal of Cancer. 9(4). 683–689. 6 indexed citations
3.
Liu, Xuefang, Xinliang Ming, Jing Wei, et al.. (2018). Long non-coding RNA XIST predicts worse prognosis in digestive system tumors: a systemic review and meta-analysis. Bioscience Reports. 38(3). 16 indexed citations
4.
Liu, Xuefang, et al.. (2018). Small Nucleolar RNA Host Gene 18 Acts as a Tumor Suppressor and a Diagnostic Indicator in Hepatocellular Carcinoma. Technology in Cancer Research & Treatment. 17. 1077062142–1077062142. 23 indexed citations
5.
Li, Nandi, Qian Tan, Jing Wei, Ping Luo, & Jiancheng Tu. (2017). Long Non-Coding RNA SPRY4-IT1 Can Predict Unfavorable Prognosis and Lymph Node Metastasis: a Meta-Analysis. Pathology & Oncology Research. 23(4). 731–736. 3 indexed citations
6.
Tan, Qian, Yalan Yu, Nandi Li, et al.. (2017). Identification of long non-coding RNA 00312 and 00673 in human NSCLC tissues. Molecular Medicine Reports. 16(4). 4721–4729. 15 indexed citations
7.
Zhu, Man, Nandi Li, Jing Wei, et al.. (2017). Peripheral Blood Leukocyte Expression of lncRNA MIAT and Its Diagnostic and Prognostic Value in Ischemic Stroke. Journal of Stroke and Cerebrovascular Diseases. 27(2). 326–337. 79 indexed citations
8.
Tan, Qian, Shili Qiu, Yalan Yu, et al.. (2017). Identification of circulating long non-coding RNA GAS5 as a potential biomarker for non-small cell lung cancer diagnosis. International Journal of Oncology. 50(5). 1729–1738. 50 indexed citations
9.
Luo, Ping, Xuefang Liu, Yingchao Wang, et al.. (2017). Prognostic value of abnormally expressed lncRNAs in ovarian carcinoma: a systematic review and meta-analysis. Oncotarget. 8(14). 23927–23936. 31 indexed citations
10.
Li, Nandi, Qian Tan, Jing Wei, et al.. (2017). Identification of Circulating Long Noncoding RNA Linc00152 as a Novel Biomarker for Diagnosis and Monitoring of Non-Small-Cell Lung Cancer. Disease Markers. 2017. 1–8. 41 indexed citations
11.
Luo, Ping, Jing Wei, Man Zhu, et al.. (2017). Decreased expression of LncRNA SRA1 in hepatocellular carcinoma and its clinical significance. Cancer Biomarkers. 18(3). 285–290. 19 indexed citations
12.
Li, Nandi, Yingchao Wang, Xuefang Liu, et al.. (2017). Identification of Circulating Long Noncoding RNA HOTAIR as a Novel Biomarker for Diagnosis and Monitoring of Non–Small Cell Lung Cancer. Technology in Cancer Research & Treatment. 16(6). 1060–1066. 67 indexed citations
13.
Zhu, Man, Jing Wei, Nandi Li, et al.. (2016). Diagnostic Potential of Differentially Expressed Homer1 and Homer2 in Ischemic Stroke. Cellular Physiology and Biochemistry. 39(6). 2353–2363. 3 indexed citations
14.
Wei, Jing, Nandi Li, Yingchao Wang, et al.. (2016). The prognostic significance of long noncoding RNAs in non-small cell lung cancer: a meta-analysis. Oncotarget. 8(3). 3957–3968. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kelin She Breakdown of academic impact, for papers by Qiming Shen Breakdown of academic impact, for papers by Miaojun Zhu Breakdown of academic impact, for papers by Changyi Fang Breakdown of academic impact, for papers by Shuzhi Zang Breakdown of academic impact, for papers by Chunni Fan Breakdown of academic impact, for papers by Sen Meng Breakdown of academic impact, for papers by Serena Di Cecilia
Rankless by CCL
2026